(Q33562288)

28 July 2017

Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest) (English)

1 reference

28 July 2017

0 references

Mona Munteanu

8

0 references

Thierry Poynard

object named as

Thierry Poynard

1

0 references

Vlad Ratziu

14

object named as

Vlad Ratziu

1 reference

28 July 2017

6

Yen Ngo

1 reference

28 July 2017

9

Fabienne Drane

1 reference

28 July 2017

10

Djamila Messous

1 reference

28 July 2017

3

Patrick Ingiliz

1 reference

28 July 2017

2

Pascal Lebray

1 reference

28 July 2017

13

Julien Massard

1 reference

28 July 2017

Anne Varaut

4

1 reference

28 July 2017

Brigitte Varsat

5

1 reference

28 July 2017

Pascal Norha

7

1 reference

28 July 2017

Françoise Imbert Bismut

11

1 reference

28 July 2017

Jean Pierre Carrau

12

1 reference

28 July 2017

Jean Pierre Giordanella

15

1 reference

28 July 2017

22 April 2010

1 reference

28 July 2017

1 reference

28 July 2017

10

1 reference

28 July 2017

40

1 reference

Creative Commons Attribution 2.0 Generic

28 July 2017

start time

22 April 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1471-230x-10-40

0 references

cites work

Screening and prostate-cancer mortality in a randomized European study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

FibroTest-ActiTest as a non-invasive marker of liver fibrosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

Diagnosis and quantitation of fibrosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

Performance of transient elastography for the staging of liver fibrosis: a meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

Reversal of hepatic fibrosis -- fact or fantasy?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multic

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

Screening for liver cancer: results of a randomised controlled trial in Qidong, China

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

Sampling variability of liver fibrosis in chronic hepatitis C.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

The prevalence and etiology of elevated aminotransferase levels in the United States

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

A comparison of fibrosis progression in chronic liver diseases

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

The U.S. Preventive Services Task Force Guide to Clinical Preventive Services, Second Edition. AMA Council on Scientific Affairs.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

Cancer screening: Evidence and practice in Europe 2008

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864202

Liver biopsy: The best standard…when everything else fails

31 October 2018

1 reference

12 December 2020

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

1 reference

12 December 2020

Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia

1 reference

12 December 2020

Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia

1 reference

12 December 2020

Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-230X-10-40

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference